Increased Cerebrospinal Fluid and Serum Nitrite and Nitrate Levels in Amyotrophic Lateral Sclerosis

References

• Alcaz S., Jarebinski M., Pekmezovic T., Stevic‐Marinkovic Z., Pavlovic S., Apostolski S. Epidemiological and clinical characteristics of ALS in Belgrade, Yugoslavia. Acta Neurologica Scandanivica 1996; 94: 264–268
   PubMed Web of Science ®Google Scholar
• Camu W., Billiard M., Baldy‐Moulinier M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurologica Scandanivica 1993; 88: 51–55
   PubMed Web of Science ®Google Scholar
• Chan P. H. Oxygen radicals in focal cerebral ischemia. Brain Pathology 1994; 4: 59–65
   PubMed Web of Science ®Google Scholar
• Dawson V. L., Dawson T. M. Nitric oxide neurotoxicity. Journal of Chemical Neuroanatomy 1996; 10: 179–190
   PubMed Web of Science ®Google Scholar
• Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., Macgarvey U., Kowall N. W., Brown R. H., Beal M. F. Evidence of increased oxtdative damage in both sporadic and familial amyotrophic lateral sclerosis. Journal of Neurochemistry 1997; 69: 2064–2074
   PubMed Web of Science ®Google Scholar
• Ferris D. C., Kume‐Kick J., Russo‐Menna I., Rice M. E. Gender differences in cerebral ascorbate levels and ascorbate loss in ischemia. Neuroreport 1995; 6: 1485–1489
   PubMedGoogle Scholar
• Garafalo O., Figlewiez D. A., Leigh P. N., Powell J. F., Meininger V., Dib M., Rouleau G. A. Androgen receptor gene polymorphisms in amyotrophic lateral selerosis. Neuromuscular Disorders 1993; 3: 195–199
   PubMedGoogle Scholar
• Hugon J., Tabaraud F., Rigaud M., Vallat J. M., Dumas M. Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease. Neurology 1989; 39: 956–958
   PubMedGoogle Scholar
• Ikeda M., Sato I., Yuasa T., Miyatake T., Murota S. Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic disease. Journal of Neural Transmission 1995; 100: 263–267
   Web of Science ®Google Scholar
• Iwasaki Y., Ikeda K., Kinoshita M. Plasma amino acid levels in patients with amyotrophic lateral sclerosis. Journal of Neurological Sciences 1992; 107: 219–222
   PubMedGoogle Scholar
• Koylu E. O., Demirgoren S., Taskiran D., Kuhar M. J., Pogun S. In vivo nitric oxide synthase (NOS) inhibition facilitates dopamine and glutamate transport. 1998, http://www.mcmaster.ca/inabis98/simantov/koylu0147/index.html
   Google Scholar
• Lanska D. Geographic distribution of stroke mortality in the United States: 1939–1941 to 1979–1981. Neurology 1993; 43: 1839–1851
   PubMed Web of Science ®Google Scholar
• McGuire V., Longstreth W. T., Nelson L. M., Koepsell T. D., Checkoway H., Morgan M. S., van Belle G. Occupational exposures and amyotrophic lateral sclerosis. A population‐based case control study. American Journal of Epidemiology 1997; 145: 1076–1088
   PubMed Web of Science ®Google Scholar
• Milstien S., Sakai N., Brew B. J., Krieger C., Vickers J. H., Saito K., Heyes M. P. Cerebrospinal fluid nitrite/nitrate levels in neurologic disease. Journal of Neurochemistry 1994; 63: 1178–1180
   PubMed Web of Science ®Google Scholar
• Norris F., Shepherd R., Denys E., Mukai E., Elias L., Holden D., Norris H. Onset, natural history and outcome in idiopathic adult motor neuron disease. Journal of Neurological Sciences 1993; 118: 48–55
   PubMed Web of Science ®Google Scholar
• Perry T. L., Krieger C., Hansen S., Eisen A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Annals of Neurology 1990; 28(1)12–17
   PubMed Web of Science ®Google Scholar
• Pogun S., Kuhar M. J. Regulation of neurotransmitter reuptake by nitrie oxide. Annals of the New York Academy of Sciences 1994; 738: 316–325
   PubMedGoogle Scholar
• Rhodes P., Leone A. M., Francis P. L., Struthers A. D., Moncada S. The Larginine: nitrie oxide pathway is the major source of plasma nitrite in fasted humans. Biochemical and Biophysical Research Communications 1995; 209(2)590–596
   PubMedGoogle Scholar
• Rothstein J. D. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Advances in Neurology 1995; 68: 7–20
   PubMedGoogle Scholar
• Rothstein J. D., Jin L., Dykes‐Hoberg M., Kunel R. W. Chronic glutamate uptake inhibition produces a model of slow neurotoxicity. Proceedings of the National Academy of Sciences of the USA. 1993; 90: 6591–6595
   Google Scholar
• Rothsteić J. D., Martin L. J., Kunel R. W. Decreased glutamate transport by the rain and spinal cord in amyotrophic lateral sclerosis. New England Journal of Medicine 1992; 326: 1464–1468
   PubMedGoogle Scholar
• Rothstein J. D., Tsai G., Kunel R. W., Clawson L., Cornblath D. R., Drachman D. B., Pestronk A., Stauch B. L., Coyle J. T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Annals of Neurology 1990; 28: 18–25
   PubMed Web of Science ®Google Scholar
• Tandan R., Bradley W. G. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology and ethical issues in management. Annals of Neurology 1985; 184: 271–280
   Google Scholar
• Taskiran D., Kutay F. Z., Sozraen E., Pogun S. Sex differences in nitrite nitrate levels and antioxidant defense in rat brain. Neuroreport 1997; 8(4)881–884
   PubMed Web of Science ®Google Scholar
• Veiga‐Cabo J., Almazan‐Isla J., Sendra‐Gutierre J. M., de Pedro‐Cuesta J. Differential features of motor neuron disease mortality in Spain. International Journal of Epidemiology 1997; 26: 1024–1032
   PubMed Web of Science ®Google Scholar